CurifyLabs is transforming personalized drug manufacturing through its digital and automated TailoredCure technology. We offer a Personalized Medicine as a Service concept for pharmacies, hospital pharmacies and veterinarians which saves time, delivers better and sustainable future treatments to patients.
Location: Finland, Mainland Finland, Helsinki
Employees: 1-10
Total raised: $10.4M
Founded date: 2021
Funding Rounds 2
| Date | Series | Amount | Investors |
| 02.06.2025 | - | $7.67M | - |
| 03.04.2023 | Grant | $2.72M | - |
Mentions in press and media 11
| Date | Title | Description |
| 02.06.2025 | CurifyLabs raises EUR 6.7 million to make compounded medications safer and more personalized | CurifyLabs raises EUR 6.7 million to make compounded medications safer and more personalized Mon, Jun 02, 2025 13:50 CET Report this content Automating the manufacturing process of compounded medicines provides patients access to safer and ... |
| 30.05.2025 | CurifyLabs Raises €6.7M in Funding | CurifyLabs, a Helsinki, Finland-based healthtech company providing a solution to automate the manufacturing of compounded medicine, raised €6.7M in funding. The round was led by Springvest with participation from Business Finland. The compa... |
| 29.05.2025 | CurifyLabs: Pioneering the Future of Personalized Medicine | In the heart of Helsinki, a revolution is brewing in the world of pharmaceuticals. CurifyLabs, a Finnish HealthTech startup, has secured €6.7 million in funding to reshape the landscape of compounded medications. This infusion of capital br... |
| 27.05.2025 | CurifyLabs secures €6.7M to launch RoboPharma and redefine drug supply resilience | Finnish healthtech company CurifyLabs has raised €6.7 million to modernise and automate the manufacturing of compounded medications, making them safer and better suited for the specific, individual needs of patients. This raise brings its f... |
| 27.05.2025 | Finnish HealthTech startup CurifyLabs raises €6.7 million to make medicine safer and more personalised | Helsinki-based CurifyLabs, a HealthTech company, has raised €6.7 million to moderniwe and automate the manufacturing of compounded medications, aiming to make them safer and better suited for the specific, individual needs of patients. The ... |
| 24.10.2023 | CurifyLabs launches GMP Pharma Inks for on-site 3D printing of personalized medicines | Pharmaceutical customization technology developer CurifyLabs has launched Good Manufacturing Practice (GMP) developed Pharma Inks for on-site production of patient-tailored and personalized medicines in pharmacies and hospitals. Unlike the ... |
| 03.04.2023 | Finnish medtech CurifyLabs secures €2.5M in grant from EIC Accelerator | Finnish medtech CurifyLabs secures €2.5M in grant from EIC Accelerator 03 April, 2023, 13:11 Rostyslav Sobachynskyi --> --> --> -->--> --> --> --> --> --> --> --> --> Helsinki-based pharmaceutical c... |
| 03.04.2023 | Finland’s CurifyLabs awarded €2.5 million from European Innovation Council | Finnish med-tech CurifyLabs has been awarded a grant of €2.5 million from the European Innovation Council (EIC) Accelerator programme to further its MiniLab technology. The EIC Accelerator award supports start-up companies in developing and... |
| 24.07.2022 | Triastek and Eli Lilly partner to 3D print gastrointestinal drugs | Chinese drug 3D printing firm Triastek has announced a partnership with global pharmaceuticals company Eli Lilly to research and develop 3D printed oral drugs for the gastrointestinal tract. Specifically, the project will leverage Triastek’... |
| 28.02.2022 | CurifyLabs and Natural Machines to launch affordable, “pharma-compliant” drug 3D printing technology in 2022 | Pharmaceutical customization technology developer CurifyLabs has partnered with food printing firm Natural Machines with the aim of bringing a new low-cost drug 3D printer to market. Working together, the companies say they’ve developed a “... |
Show more